1. Chronic lymphocytic leukemia (CLL) treatment: So many choices, such great options
2. B-cell receptor signaling in chronic lymphocytic leukemia
3. FDA Alerts Healthcare Professionals About Clinical Trials with Zydelig (idelalisib) in Combination with other Cancer Medicines. 2016. Available at: https://www.fda.gov/drugs/drug-safety-and-availability/fda-alerts-healthcare-professionals-about-clinical-trials-zydelig-idelalisib-combination-other .
4. Duvelisib (COPIKTRA, Verastem, Inc.) For adult patients with relapsed or refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). 2018. Available at: https://www.fda.gov/drugs/resources-information-approved-drugs/duvelisib-copiktra-verastem-inc-adult-patients-relapsed-or-refractory-chronic-lymphocytic-leukemia.
5. Molecular and cellular mechanisms of CLL: novel therapeutic approaches